QuidelOrtho Earnings
NASDAQ: QDELHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$0.18
QuidelOrtho earnings summary
QuidelOrtho is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $0.18. In its most recent report on Aug 6, 2026 (Q2 2026), QDEL posted EPS of $-1.36. Revenue for the quarter was $630.9 million.
Across the last 16 reports, QDEL shares moved an average of 5.9% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
QDEL earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-1.36 | — | +16.4% |
| Apr 15, 2026 | — | $-1.35 | — | -8.8% |
| Feb 11, 2026 | — | $-1.95 | — | -4.7% |
| Nov 5, 2025 | — | $-10.78 | — | +4.9% |
| Aug 5, 2025 | — | $-3.77 | — | +8.4% |
| May 7, 2025 | — | $-0.19 | — | -7.9% |
| Jan 13, 2025 | — | $-2.54 | — | +6.0% |
| Nov 8, 2024 | — | $-0.30 | — | -17.3% |
| Aug 1, 2024 | — | $-2.20 | — | -0.9% |
| May 9, 2024 | — | $-25.50 | — | +0.5% |
| Feb 29, 2024 | — | $0.11 | — | +1.6% |
| Nov 2, 2023 | — | $-0.19 | — | -7.7% |
| Aug 9, 2023 | — | $-0.80 | — | -4.7% |
| May 4, 2023 | — | $0.73 | — | -1.5% |
| Feb 23, 2023 | — | $-2.39 | — | +0.9% |
| Nov 4, 2022 | — | $0.28 | — | +2.8% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.